Teva files second amended US antitrust complaint against Corcept, Optime
MLex Summary: Teva Pharmaceuticals filed its second amended complaint against Corcept Therapeutics and Optime Care "for pervasive and highly damaging antitrust violations." Corcept and Optime "have been engaged in an ongoing scheme...To view the full article, register now.
Already a subscriber? Click here to view full article